S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

ENLV Enlivex Therapeutics Ltd

1.07

0.1407 (15.14%)

Last Updated: 07:40:28

Delayed by 15 minutes

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

null

Enlivex Therapeutics (NASDAQ:ENLV)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Enlivex Therapeutics Charts.

Enlivex Therapeutics (NASDAQ:ENLV)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Enlivex Therapeutics Charts.

Enlivex Therapeutics Ltd News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 21 November 2024 (5 days ago) • Edgar (US Regulatory)

Enlivex Adopts Bitcoin Treasury Reserve Strategy
Thursday 21 November 2024 (5 days ago) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Friday 15 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 15 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Enlivex Announces the Dosing of the First Patient in a Phase I Clinical Trial Evaluating Allocetra in Patients with Psoriatic Arthritis
Friday 15 November 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 13 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Enlivex Announces the Enrollment and Dosing of the First 10 Patient in the Randomized Phase II Stage of its Allocetra Trial in Patients with Moderate to Severe Knee Osteoarthritis
Wednesday 13 November 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 1 November 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 30 October 2024 (4 weeks ago) • Edgar (US Regulatory)

Enlivex Receives Notice of Allowance for Japanese Patent Application Covering the Use of Allocetra™ in Patients with Osteoarthritis
Wednesday 30 October 2024 (4 weeks ago) • GlobeNewswire Inc.

Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
Tuesday 15 October 2024 (1 month ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 26 September 2024 (2 months ago) • Edgar (US Regulatory)

More Enlivex Therapeutics Ltd News Articles

JP Morgan Chase

Gold vs US Dollar

Sterling vs AUD

Australia And New Zealan...

Verizon Communications

Australian SE All Ordina...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions